Important Conversations at AIRWAYS 2025
- TRACKER Biobank
- Sep 1
- 2 min read
The TRACKER team featured at the AIRWAYS 2025 Conference in Melbourne, contributing to important discussions on lung health. The event provided a valuable platform to share insights, explore innovations in early detection, and highlight the role of collaborative approaches in advancing respiratory care.
Driving Innovation in Lung Health
The AIRWAYS 2025 Conference in Melbourne brought together leading clinicians, researchers, and health professionals to share knowledge and explore the latest innovations in respiratory health. Designed to inspire collaboration and spark fresh ideas, the event featured clinical perspectives and discussions on the future of lung health care.
This year’s program showcased early detection, innovative diagnostics, and the translation of research into improved patient care, which are all key drivers in improving outcomes for people living with lung disease.

TRACKER Team on the Stage
The TRACKER team was proud to contribute to these important conversations. Dr Senthuran Shivakumar, TRACKER PhD candidate, delivered a thought-provoking presentation titled “Ground glass changes in lung cancer patients — what’s next?” Sen explored the clinical complexities of identifying and managing these subtle early changes in lung tissue, sharing early findings from his research that may open new directions for patient care.
“Ground glass changes can be difficult to interpret, but they offer important clues for improving early detection and patient care,” Sen said. “Our aim is to better understand these changes so that care can be refined and outcomes improved.”
His presentation sparked engaging discussions, highlighting the importance of multidisciplinary collaboration in tackling challenging clinical questions.
Shaping the Future of Screening and Care
Another highlight was Dr Tracy Leong chairing the session “From detection to direction: lung cancer management in the screening age.” The discussion explored how national screening programs are reshaping lung cancer care, enabling earlier diagnosis, refining treatment pathways, and ultimately improving outcomes for patients.
The session underscored a clear message: early intervention, guided by strong evidence and comprehensive data, is key to extending survival and enhancing quality of life.
Supporting Collaboration
We thank Boehringer Ingelheim for their generous support of the AIRWAYS 2025 Conference. It offered a valuable opportunity for the TRACKER team to exchange ideas, strengthen collaborations, and help shape the future of lung health. It also served as a powerful reminder that real progress comes from shared knowledge, innovation, and a united commitment to changing the landscape of lung disease.








Comments